Is development of postoperative venous thromboembolism related to thromboprophylaxis use? A case-control study in the veterans health administration

Joint Commission Journal on Quality and Patient Safety

Volumn 38, Issue 8, 2012, Pages 348-358

  Borzecki, Ann M ^a   Cowan, Andrew J ^b   Cevasco, Marisa ^c   Shin, Marlena H ^d   Shwartz, Michael ^d   Itani, Kamal ^d,e   Rosen, Amy K ^d,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d VA BOSTON HEALTHCARE SYSTEM   (United States)

^e HARVARD UNIVERSITY   (United States)

^f BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ARTICLE; ELECTRONIC MEDICAL RECORD; FEMALE; GOVERNMENT; HUMAN; LENGTH OF STAY; LUNG EMBOLISM; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RISK FACTOR; SOCIOECONOMICS; STATISTICS; UNITED STATES; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PULMONARY EMBOLISM; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VENOUS THROMBOEMBOLISM;

EID: 84864221002     PISSN: 15537250     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1553-7250(12)38045-8     Document Type: Review

References (43)

1. Geerts WH, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):381S-453S. (Pubitemid 351894916)
2. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003 Oct. 8;290(14):1868-1874. (Pubitemid 37430603)
3. Gangireddy C, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. JVasc Surg. 2007;45(2):335-341; discussion 341-342.
4. Collins R, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988 May 5;318(18):1162-1173.
5. Mismetti P, et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88(7):913-930. (Pubitemid 34015572)
6. Hull RD, Raskob GE, Hirsh J. Prophylaxis of venous thromboembolism. An overview. Chest. 1986;89(5 Suppl):374S-383S.
7. Amin A, et al. Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start). J Thromb Thrombolysis. 2010;29(3):326-339.
8. Dorfman M, Chan SB, Maslowski C. Hospital-acquired venous thromboembolism and prophylaxis in an integrated hospital delivery system. J Clin Pharm Ther. 2006;31(5):455-459. (Pubitemid 44337294)
9. Kakkar AK, et al. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): Findings in surgical patients. Ann Surg. 2010;251(2):330-338.
10. The Joint Commission: Specifications Manual for National Hospital Inpatient Quality Measures. Version 4.1.1. Accessed Jun 28, 2012. http://www.jointcommission.org/specifications-manual-for-national -hospital-inpatient-quality-measures.aspx.
11. Agency for Healthcare Research and Quality. AHRQ Quality Indicators: Guide to Patient Safety Indicators. Version 3.1. Mar 12, 2007. Accessed Jun 28, 2012. http://qualityindicators.ahrq.gov/Downloads/Software/SAS/V31/ psi-guide-v31.pdf.
12. Centers for Medicare & Medicaid Services. Fiscal Year 2009 Quality Measure Reporting for 2010 Payment Update. Accessed Jun 28, 2012. http://www.cms.hhs.gov/HospitalQualityInits/downloads/Hospital RHQDAPU200808.pdf.
13. QualityNet. Hospital Inpatient Quality Reporting (IQR) Program Overview: Resources for Fiscal Year 2013 Payment Determination. Program Changes/Updates. Accessed Jun 28, 2012. http://www.qualitynet.org/dcs /ContentServer?cid= 1138115987129&pagename=QnetPublic%2FPage%2FQ netTier2&c=Page.
14. Centers for Medicare & Medicaid Services. Hospital-Acquired Conditions (Present on Admission Indicator). (Updated May 1, 2012.) Accessed Jun 28, 2012. http://www.cms.gov/HospitalAcqCond/06-Hospital-Acquired-Conditions. asp#TopOf Page.
15. Weingart SN, et al. Use of administrative data to find substandard care: Validation of the complications screening program. Med Care. 2000;38(8): 796-806.
16. Shackford SR, et al. A 10-year analysis of venous thromboembolism on the surgical service: The effect of practice guidelines for prophylaxis. Surgery. 2008;144(1):3-11. (Pubitemid 351832819)
17. Schleyer AM, et al. Adherence to guideline-directed venous thromboembolism prophylaxis among medical and surgical inpatients at 33 academic medical centers in the United States. Am J Med Qual. 2011;26(3):174-180.
18. Weigelt JA, Lal A, Riska R. Venous thromboembolism prophylaxis in surgical patients: Identifying a patient group to maximize performance improvement. Jt Comm J Qual Patient Saf. 2011;37(4):178-183.
19. Herbers J, Zarter S. Prevention of venous thromboembolism in Department of Veterans Affairs hospitals. J Hosp Med. 2010;5(1):E21-5.
20. ® Inpatient Datasets. Jan 2003. Sep 2007. Accessed Jul 5, 2012. http://www.virec.research.va.gov/RUGs/ MedSAS-Archive/IP/RUG-MedSAS-IP-FY06-ER.pdf.
21. Rosen AK, et al. Evaluating the patient safety indicators: How well do they perform on Veterans Health Administration data? Med Care. 2005;43(9): 873-884. (Pubitemid 41323136)
22. US Department of Veterans Affairs, Veterans Health Administration. VistAWeb Technical Manual. Jan 2010. Accessed Jun 28, 2012. http://www.va.gov/ vdl/documents/Clinical/VistaWeb/webv-1-19-tm.pdf.
23. Kaafarani HM, et al. Validity of selected Patient Safety Indicators: Opportunities and concerns. J Am Coll Surg. 2011;212(6):924-934.
24. Agency for Healthcare Research and Quality. AHRQ Quality Indicators: Patient Safety Indicators: Technical Specifications. Version 3.1 Mar 12, 2007. Accessed Jun 28, 2012. http://www.qualityindicators.ahrq.gov/Downloads/ Modules/PSI/V31/psi-technical-specs-v31.pdf.
25. Goldhaber SZ, Dunn K, MacDougall RC. New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest. 2000;118(6):1680-1684. (Pubitemid 32001795)
26. QualityNet. Specifications Manual, Version 2.6b: Discharges 04/01/2009 to 09/30/2009. Accessed Jun 27, 2012. http://www.qualitynet.org/dcs/ContentServer? c=Page&pagename=QnetPublic%2FPage%2FQnetTier4&cid=1221491528970. Appendix A - ICD-9 Code Tables, revised Nov 19, 2008 (Tables 5.19, 5.21, 5.22, 5.23, and 5.24).
27. Healthcare Cost and Utilization Project. Comorbidity Software, Version 3.7: Overview of Cormorbidity Software. Apr 2012. (Updated Apr 20, 2012.) Accessed Jun 28, 2012. http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity /comorbidity.jsp#overview.
28. Agency for Healthcare Research and Quality. AHRQ Quality Indicators Validation Pilot. Accessed Jun 28, 2012. http://qualityindicators.ahrq.gov/ ValidationPilot.aspx.
29. National Institute for Health and Clinical Excellence. Venous Thromboembolism: Reducing the Risk. NICE Clinical Guideline 92. Jun 2010. Accessed Jun 28, 2012. http://guidance.nice.org.uk/CG92/NICEGuidance/pdf/ English.
30. Baglin T, et al. Guidelines on the use and monitoring of heparin. Br J Haematol. 2006;133(1):19-34. (Pubitemid 43327194)
31. Geerts WH, et al. Prevention of venous thromboembolism. Chest. 2001;119(1 Suppl):132S-175S. (Pubitemid 32162075)
32. Geerts WH, et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):338S-400S. (Pubitemid 39302602)
33. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
34. Agnelli G, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS project. Ann Surg. 2006;243(1):89-95. (Pubitemid 43054059)
35. Fonarow GC, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007 Jan 3;297(1):61-70. (Pubitemid 46041727)
36. Werner RM., Bradlow ET. Relationship between Medicare's Hospital Compare performance measures and mortality rates. JAMA. 2006 Dec 13; 296(22):2694-2702. (Pubitemid 44920181)
37. Ingraham AM, et al. Association of Surgical Care Improvement Project infection-related process measure compliance with risk-adjusted outcomes: implications for quality measurement. J Am Coll Surg. 2010;211(6):705-714.
38. Guyatt GH, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):7S-47S.
39. Cohen AT, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study. Lancet. 2008 Feb 2;371(9610):387-394. (Pubitemid 351173321)
40. Amin AN, et al. Preventing venous thromboembolism in US hospitals: Are surgical patients receiving appropriate prophylaxis? Thromb Haemost. 2008;99(4):796-797. (Pubitemid 351694244)
41. Rosen AK, et al. Validating the Patient Safety Indicators in the Veterans Health Administration: Do they accurately identify true safety events?. Med Care. 2012;50(1):74-85.
42. Classen DC, et al. "Global trigger tool" shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff (Millwood). 2011;30(4):581-589.
43. Heit JA. Estimating the incidence of symptomatic postoperative venous thromboembolism: The importance of perspective. JAMA. 2012 Jan 18;307(3):306-307.